Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;63(4):262-265.
doi: 10.3960/jslrt.23043.

Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma

Yasunobu Sekiguchi  1 , Hiroki Tsutsumi  1 , Ayumi Gomyo  1 , Masahisa Kudo  1 , Yoshie Iizaki  1 , Nobuo Maseki  1 , Machiko Kawamura  1   2 , Kazuhiko Kobayashi  3 , Yu Nishimura  4 , Hiroaki Kanda  4 , Hideaki Nitta  5 , Masaaki Noguchi  5 , Hirofumi Kobayashi  1
Affiliations

Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma

Yasunobu Sekiguchi et al. J Clin Exp Hematop. 2023.
No abstract available

Keywords: 80 years over; POLARIX; Pola-R-mini-CHP; R-mini-CHOP; diffuse large B-cell lymphoma.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors report there are no competing interest to declare.

Figures

Fig. 1
Fig. 1
Changes in each patient’s response over time
See this image and copyright information in PMC

References

    1. Tsutsué S, Tobinai K, Yi J, Crawford B. Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma. PLoS One. 2020; 15: e0237509. - PMC - PubMed
    1. Hiroi T, Hosoi H, Kuriyama K, et al. An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma: A multicenter retrospective cohort study. J Geriatr Oncol. 2023; 14: 101396. - PubMed
    1. Morrison VA, Hamlin P, Soubeyran P, et al. Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper. J Geriatr Oncol. 2015; 6: 141-152. - PubMed
    1. Tavares A, Moreira I. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment - A systematic review. Crit Rev Oncol Hematol. 2021; 160: 103294. - PubMed
    1. Edited by the Japanese Society of Hematology. Practical Guidelines for Hematological Malignancies, 2023. Tokyo, Kanehara & Co. pp. 278-302.

MeSH terms